Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension

Journal of Cardiothoracic Surgery

Volumn 5, Issue 1, 2010, Pages

  Ochoa, Cristhiaan D ^a   Yu, Lunyin ^a   Al Ansari, Essam ^a   Hales, Charles A ^a   Quinn, Deborah A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; THROMBOSPONDIN 1; VASOCONSTRICTOR AGENT;

ANIMAL; ANOXIA; ARTICLE; DRUG EFFECT; GENETICS; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE HYPERTROPHY; MALE; MOUSE; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY ARTERY; PULMONARY HYPERTENSION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; ANOXIA; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; PULMONARY ARTERY; THROMBOSPONDIN 1; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VENTRICULAR FUNCTION, RIGHT;

EID: 77952861606     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-5-32     Document Type: Article

References (40)

1. Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H, Hynes RO. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 1998, 101(5):982-992. 10.1172/JCI1684, 508649, 9486968.
2. Chen H, Herndon ME, Lawler J. The cell biology of thrombospondin-1. Matrix Biol 2000, 19(7):597-614. 10.1016/S0945-053X(00)00107-4, 11102749.
3. Maier KG, Sadowitz B, Cullen S, Han X, Gahtan V. Thrombospondin-1-induced vascular smooth muscle cell migration is dependent on the hyaluronic acid receptor CD44. Am J Surg 2009, 198(5):664-669. 10.1016/j.amjsurg.2009.07.018, 19887196.
4. Wang XJ, Maier K, Fuse S, Willis AI, Olson E, Nesselroth S, Sumpio BE, Gahtan V. Thrombospondin-1-induced migration is functionally dependent upon focal adhesion kinase. Vasc Endovascular Surg 2008, 42(3):256-262. 10.1177/1538574408314440, 18319354.
5. Bornstein P. Thrombospondins as matricellular modulators of cell function. J Clin Invest 2001, 107(8):929-934. 10.1172/JCI12749, 199563, 11306593.
6. Friedl P, Vischer P, Freyberg MA. The role of thrombospondin-1 in apoptosis. Cell Mol Life Sci 2002, 59(8):1347-1357. 10.1007/s00018-002-8512-9, 12363037.
7. Lawler J. The functions of thrombospondin-1 and-2. Curr Opin Cell Biol 2000, 12(5):634-640. 10.1016/S0955-0674(00)00143-5, 10978901.
8. Lawler J, Detmar M. Tumor progression: the effects of thrombospondin-1 and -2. Int J Biochem Cell Biol 2004, 36(6):1038-1045. 10.1016/j.biocel.2004.01.008, 15094119.
9. Chatila K, Ren G, Xia Y, Huebener P, Bujak M, Frangogiannis NG. The role of the thrombospondins in healing myocardial infarcts. Cardiovasc Hematol Agents Med Chem 2007, 5(1):21-27.
10. Esemuede N, Lee T, Pierre-Paul D, Sumpio BE, Gahtan V. The role of thrombospondin-1 in human disease(1). J Surg Res 2004, 122(1):135-142. 10.1016/j.jss.2004.05.015, 15522326.
11. Idell S, Maunder R, Fein AM, Switalska HI, Tuszynski GP, McLarty J, Niewiarowski S. Platelet-specific alpha-granule proteins and thrombospondin in bronchoalveolar lavage in the adult respiratory distresssyndrome. Chest 1989, 96(5):1125-32. 10.1378/chest.96.5.1125, 2530064.
12. Ide M, Ishii H, Mukae H, Iwata A, Sakamoto N, Kadota J, Kohno S. High serum levels of thrombospondin-1 in patients with idiopathic interstitial pneumonia. Respiratory medicine 2008, 102(11):1625-30. 10.1016/j.rmed.2008.05.009, 18640828.
13. Wang IM, Stepaniants S, Boie Y, Mortimer JR, Kennedy B, Elliott M, Hayashi S, Loy L, Coulter S, Cervino S, Harris J, Thornton M, aubertas R, oberts C, Hogg JC, Crackower M, O'Neill G, Paré P. Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. Am J Respir Crit Care Med 2008, 177(4):402-11. 10.1164/rccm.200703-390OC, 17975202.
14. Kwapiszewska G, Wilhelm J, Wolff S, Laumanns I, Koenig IR, Ziegler A, Seeger W, Bohle RM, Weissmann N, Fink L. Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension. Respir Res 2005, 6:109. 10.1186/1465-9921-6-109, 1261535, 16171515.
15. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998, 93(7):1159-1170. 10.1016/S0092-8674(00)81460-9, 9657149.
16. Ochoa CD, Baker H, Hasak S, Matyal R, Salam A, Hales CA, Hancock W, Quinn DA. Cyclic stretch affects pulmonary endothelial cell control of pulmonary smooth muscle cell growth. Am J Respir Cell Mol Biol 2008, 39(1):105-12. 10.1165/rcmb.2007-0283OC, 2438445, 18314539.
17. Yu L, Quinn DA, Garg HG, Hales CA. Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice. Circ Res 2005, 97(9):937-945. 10.1161/01.RES.0000188211.83193.1a, 16195480.
18. Hales CA, Kradin RL, Brandstetter RD, Zhu YJ. Impairment of hypoxic pulmonary artery remodeling by heparin in mice. Am Rev Respir Dis 1983, 128(4):747-751.
19. Hassoun PM, Thompson BT, Hales CA. Partial reversal of hypoxic pulmonary hypertension by heparin. Am Rev Respir Dis 1992, 145(1):193-196.
20. Hassoun PM, Thompson BT, Steigman D, Hales CA. Effect of heparin and warfarin on chronic hypoxic pulmonary hypertension and vascular remodeling in the guinea pig. Am Rev Respir Dis 1989, 139(3):763-768.
21. Janssens SP, Thompson BT, Spence CR, Hales CA. Functional and structural changes with hypoxia in pulmonary circulation of spontaneously hypertensive rats. J Appl Physiol 1994, 77(3):1101-1107.
22. Janssens SP, Thompson BT, Spence CR, Hales CA. Polycythemia and vascular remodeling in chronic hypoxic pulmonary hypertension in guinea pigs. J Appl Physiol 1991, 71(6):2218-2223.
23. Quinn D, Du HK, Thompson BT, Garg HG, Hales CA. Effect of dimethyl amiloride on chronic hypoxic pulmonary hypertension in rats. Chest 1998, 114(1 Suppl):69S-70S. 10.1378/chest.114.1_Supplement.69S-a, 9676642.
24. Quinn DA, Robinson D, Hales CA. Intravenous injection of propylene glycol causes pulmonary hypertension in sheep. J Appl Physiol 1990, 68(4):1415-1420. 10.1063/1.346667, 2347783.
25. Silverman ES, Thompson BT, Quinn DA, Kinane TB, Bonventre JV, Hales CA. Na+/H+ exchange in pulmonary artery smooth muscle from spontaneously hypertensive and Wistar-Kyoto rats. Am J Physiol 1995, 269(5 Pt 1):L673-80.
26. Thompson BT, Hassoun PM, Kradin RL, Hales CA. Acute and chronic hypoxic pulmonary hypertension in guinea pigs. J Appl Physiol 1989, 66(2):920-928. 10.1063/1.343521, 2708221.
27. Thompson BT, Spence CR, Janssens SP, Joseph PM, Hales CA. Inhibition of hypoxic pulmonary hypertension by heparins of differing in vitro antiproliferative potency. Am J Respir Crit Care Med 1994, 149(6):1512-1517.
28. Thompson BT, Steigman DM, Spence CL, Janssens SP, Hales CA. Chronic hypoxic pulmonary hypertension in the guinea pig: effect of three levels of hypoxia. J Appl Physiol 1993, 74(2):916-921.
29. Zhu YJ, Kradin R, Brandstetter RD, Staton G, Moss J, Hales CA. Hypoxic pulmonary hypertension in the mast cell-deficient mouse. JAppl Physiol 1983, 54(3):680-686.
30. Quinn DA, Du HK, Thompson BT, Hales CA. Amiloride analogs inhibit chronic hypoxic pulmonary hypertension. Am J Respir Crit Care Med 1998, 157(4 Pt 1):1263-1268.
31. Du HK, Lee YJ, Colice GL, Leiter JC, Ou LC. Pathophysiological effects of hemodilution in chronic mountain sickness in rats. J Appl Physiol 1996, 80(2):574-582.
32. Baber SR, Deng W, Rodriguez J, Master RG, Bivalacqua TJ, Hyman AL, Kadowitz PJ. Vasoactive prostanoids are generated from arachidonic acid by COX-1 and COX-2 in the mouse. Am J Physiol Heart Circ Physiol 2005, 289(4):H1476-87. 10.1152/ajpheart.00195.2005, 15863457.
33. Sage E, Mercier O, Eyden F, de Perrot M, Barlier-Mur AM, Dartevelle P, Eddahibi S, Herve P, Fadel E. Endothelial cell apoptosis in chronically obstructed and reperfused pulmonary artery. Respir Res 2008, 9:19. 10.1186/1465-9921-9-19, 2263036, 18269754.
34. Grossman PL, Remington JS. The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo. Am J Trop Med Hyg 1979, 28(3):445-455.
35. Streit M, Velasco P, Riccardi L, Spencer L, Brown LF, Janes L, Lange-Asschenfeldt B, Yano K, Hawighorst T, Iruela-Arispe L, Detmar M. Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice. EMBO J 2000, 19(13):3272-3282. 10.1093/emboj/19.13.3272, 313956, 10880440.
36. Raugi GJ, Mullen JS, Bark DH, Okada T, Mayberg MR. Thrombospondin deposition in rat carotid artery injury. Am J Pathol 1990, 137(1):179-185. 1877701, 1695483.
37. Isenberg JS, Wink DA, Roberts DD. Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses. Cardiovasc Res 2006, 71(4):785-793. 10.1016/j.cardiores.2006.05.024, 16820142.
38. Isenberg JS, Ridnour LA, Dimitry J, Frazier WA, Wink DA, Roberts DD. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem 2006, 281(36):26069-26080. 10.1074/jbc.M605040200, 16835222.
39. Isenberg JS, Martin-Manso G, Maxhimer JB, Roberts DD. Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies. Nat Rev Cancer 2009, 9(3):182-194. 10.1038/nrc2561, 2796182, 19194382.
40. Isenberg JS, Qin Y, Maxhimer JB, Sipes JM, Despres D, Schnermann J, Frazier WA, Roberts DD. Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress. Matrix Biol 2009, 28(2):110-119. 10.1016/j.matbio.2009.01.002, 2663008, 19284971.